Distinct effects of nociceptin analogs on scopolamine-induced memory impairment in mice

European Journal of Pharmacology

Volumn 602, Issue 2-3, 2009, Pages 328-333

  Miwa, Masaya ^a   Shinki, Chieko ^b   Uchida, Shogo ^a   Hiramatsu, Masayuki ^a,b  

^a Graduate School of Environmental and Human Sciences   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

(pF)Phe4 nociceptin(1 13)NH2; Arg14, Lys15 nociceptin; Memory; Nociceptin orphanin FQ; NOP receptor

Indexed keywords

MECAMYLAMINE; NALOXONE BENZOYLHYDRAZONE; NOCICEPTIN; NOCICEPTIN DERIVATIVE; NOCICEPTIN[1-13][(PROLYLPHENYLALANINE) 4 PHENYLALANINAMIDE]; NOCICEPTIN[1-13][1 N PHENYLALANINAMIDE]; NOCICEPTIN[14 ARGININE 13 LYSINE]; NOCISTATIN; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HIPPOCAMPUS; LEARNING DISORDER; LOW DRUG DOSE; MALE; MAZE TEST; MEMORY DISORDER; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; DRUG THERAPY, COMBINATION; HIPPOCAMPUS; HUMANS; INJECTIONS; MALE; MEMORY; MEMORY DISORDERS; MICE; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; SCOPOLAMINE;

EID: 58149154537     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.027     Document Type: Article

References (35)

1. Chiou L.C., Chuang K.C., Wichmann J., and Adam G. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices. J. Pharmacol. Exp. Ther. 311 (2004) 645-651
2. Darland T., and Grandy D.K. The orphanin FQ system: an emerging target for the management of pain?. Br. J. Anaesth. 81 (1998) 29-37
3. Fornari R.V., Soares J.C., Ferreira T.L., Moreira K.M., and Oliveira M.G. Effects of nociceptin/orphanin FQ in the acquisition of contextual and tone fear conditioning in rats. Behav. Neurosci. 122 (2008) 98-106
4. Goeldner C., Reiss D., Wichmann J., Meziane H., Kieffer B.L., and Ouagazzal A.M. Nociceptin receptor impairs recognition memory via interaction with NMDA receptor-dependent mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in the hippocampus. J. Neurosci. 28 (2008) 2190-2198
5. 2: identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J. Med. Chem. 44 (2001) 3956-3964
6. Haley T.J., and McCormick W.G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J Pharmacol. Chemother. 12 (1957) 12-15
7. Higgins G.A., Kew J.N., Richards J.G., Takeshima H., Jenck F., Adam G., Wichmann J., Kemp J.A., and Grottick A.J. A combined pharmacological and genetic approach to investigate the role of orphanin FQ in learning and memory. Eur. J. Neurosci. 15 (2002) 911-922
8. Hiramatsu M., Sasaki M., and Kameyama T. Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. Eur. J. Pharmacol. 282 (1995) 185-191
9. Hiramatsu M., Hyodo T., and Kameyama T. U-50488H, a selective κ-opioid receptor agonist, improves carbon monoxide-induced delayed amnesia in mice. Eur. J. Pharmacol. 315 (1996) 119-125
10. Hiramatsu M., Sasaki M., Nabeshima T., and Kameyama T. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice. Pharmacol. Biochem. Behav. 56 (1997) 73-79
11. Hiramatsu M., and Inoue K. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice. Br. J. Pharmacol. 127 (1999) 655-660
12. Hiramatsu M., and Inoue K. Effects of nocistatin on nociceptin-induced impairment of learning and memory in mice. Eur. J. Pharmacol. 367 (1999) 151-155
13. Hiramatsu M., and Inoue K. Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory. Eur. J. Pharmacol. 395 (2000) 149-156
14. Hiramatsu M., Miwa M., Hashimoto K., Kawai S., and Nomura N. Nociceptin/orphanin FQ reverses mecamylamine-induced learning and memory impairment as well as decrease in hippocampal acetylcholine release in the rat. Brain Res. 1195 (2008) 96-103
15. Inoue M., Matsunaga S., Rashid M.H., Yoshida A., Mizuno K., Sakurada T., Takeshima H., and Ueda H. Pronociceptive effects of nociceptin/orphanin FQ (13-17) at peripheral and spinal level in mice. J. Pharmacol. Exp. Ther. 299 (2001) 213-219
16. Kuzmin A., Sandin J., Terenius L., and Ogren S.O. Evidence in locomotion test for the functional heterogeneity of ORL-1 receptors. Br. J. Pharmacol. 141 (2004) 132-140
17. Liu E.H., Lee T.L., Nishiuchi Y., Kimura T., and Tachibana S. Nocistatin and its derivatives antagonize the impairment of short-term acquisition induced by nociceptin. Neurosci. Lett. 416 (2007) 155-159
18. Mamiya T., Noda Y., Nishi M., Takeshima H., and Nabeshima T. Nociceptin system plays a role in the memory retention: involvement of naloxone benzoylhydrazone binding sites. Neuroreport 10 (1999) 1171-1175
19. Mamiya T., Yamada K., Miyamoto Y., Konig N., Watanabe Y., Noda Y., and Nabeshima T. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-d-aspartate receptors. Mol. Psychiatry 8 (2003) 752-765
20. Manabe T., Noda Y., Mamiya T., Katagiri H., Houtani T., Nishi M., Noda T., Takahashi T., Sugimoto T., Nabeshima T., and Takeshima H. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394 (1998) 577-581
21. Mathis J.P., Ryan-Moro J., Chang A., Hom J.S., Scheinberg D.A., and Pasternak G.W. Biochemical evidence for orphanin FQ/nociceptin receptor heterogeneity in mouse brain. Biochem. Biophys. Res. Commun. 230 (1997) 462-465
22. Meunier J.C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.L., Guillemot J.C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., and Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377 (1995) 532-535
23. Nagai T., Takuma K., Kamei H., Ito Y., Nakamichi N., Ibi D., Nakanishi Y., Murai M., Mizoguchi H., Nabeshima T., and Yamada K. Dopamine D1 receptors regulate protein synthesis-dependent long-term recognition memory via extracellular signal-regulated kinase 1/2 in the prefrontal cortex. Learn. Mem. 14 (2007) 117-125
24. 14Tyr]-orphanin FQ binding. J. Comp. Neurol. 412 (1999) 563-605
25. Neal Jr. C.R., Mansour A., Reinscheid R., Nothacker H.P., Civelli O., and Watson Jr. S.J. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406 (1999) 503-547
26. Okada K., Sujaku T., Chuman Y., Nakashima R., Nose T., Costa T., Yamada Y., Yokoyama M., Nagahisa A., and Shimohigashi Y. Highly potent nociceptin analog containing the Arg-Lys triple repeat. Biochem. Biophys. Res. Commun. 278 (2000) 493-498
27. Onali P., Ingianni A., and Olianas M.C. Dual coupling of opioid receptor-like (ORL1) receptors to adenylyl cyclase in the different layers of the rat main olfactory bulb. J. Neurochem. 77 (2001) 1520-1530
28. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma Jr. F.J., and Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270 (1995) 792-794
29. 2 analogues. 2. In vivo studies. Naunyn-Schmiedeberg's Arch. Pharmacol. 365 (2002) 450-456
30. 15]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies. J. Pharmacol. Exp. Ther. 300 (2002) 57-63
31. Sandin J., Georgieva J., Schott P.A., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur. J. Neurosci. 9 (1997) 194-197
32. Sandin J., Ogren S.O., and Terenius L. Nociceptin/orphanin FQ modulates spatial learning via ORL-1 receptors in the dorsal hippocampus of the rat. Brain Res. 997 (2004) 222-233
33. Sarter M., Bodewitz G., and Stephens D.N. Attenuation of scopolamine-induced impairment of spontaneous alteration behaviour by antagonist but not inverse agonist and agonist ß-carbolines. Psychopharmacology 94 (1988) 491-495
34. Vecsey C.G., Hawk J.D., Lattal K.M., Stein J.M., Fabian S.A., Attner M.A., Cabrera S.M., McDonough C.B., Brindle P.K., Abel T., and Wood M.A. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. 27 (2007) 6128-6140
35. Watanabe H., Mizoguchi H., Orito T., Katsuyama S., Yonezawa A., Watanabe C., Sakurada T., and Sakurada S. Possible involvement of endogenous nociceptin/orphanin FQ in the pain-related behavioral responses induced by its own metabolite, nociceptin/orphanin FQ(14-17). Peptides 28 (2007) 670-677